Enabling Population Protein Dynamics Through Bayesian Modeling.


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 04 12 2023
revised: 26 06 2024
accepted: 29 07 2024
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: aheadofprint

Résumé

The knowledge of protein dynamics, or turnover, in patients provides invaluable information related to certain diseases, drug efficacy, or biological processes. A great corpus of experimental and computational methods has been developed, including by us, in the case of human patients followed in vivo. Moving one step further, we propose a novel modeling approach to capture population protein dynamics using Bayesian methods. Using two datasets, we demonstrate that models inspired by population pharmacokinetics can accurately capture protein turnover within a cohort and account for inter-individual variability. Such models pave the way for comparative studies searching for altered dynamics or biomarkers in diseases. R code and preprocessed data are available from zenodo.org. Raw data are available from panoramaweb.org. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 39078204
pii: 7723994
doi: 10.1093/bioinformatics/btae484
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Sylvain Lehmann (S)

Université de Montpellier, Montpellier, France.
LBPC-PPC CHU Montpellier, INM INSERM.

Jérôme Vialaret (J)

LBPC-PPC CHU Montpellier, INM INSERM.

Audrey Gabelle (A)

Université de Montpellier, Montpellier, France.
CMRR CHU Montpellier, INM INSERM.

Luc Bauchet (L)

Université de Montpellier, Montpellier, France.
Department of Neurosurgery, CHU Montpellier, INM INSERM.

Jean-Philippe Villemin (JP)

Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm, Montpellier U1194, France.

Christophe Hirtz (C)

Université de Montpellier, Montpellier, France.
LBPC-PPC CHU Montpellier, INM INSERM.
CMRR CHU Montpellier, INM INSERM.

Jacques Colinge (J)

Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm, Montpellier U1194, France.

Classifications MeSH